Suppr超能文献

动脉门静脉造影期间螺旋CT对肝脏恶性肿瘤大小的高估:平衡期CT与病理对照

Overestimating the size of hepatic malignancy on helical CT during arterial portography: equilibrium phase CT and pathology.

作者信息

Kanematsu M, Hoshi H, Yamada T, Nandate Y, Kato M, Yokoyama R, Murakami T, Nakamura H

机构信息

Department of Radiology, Gifu University School of Medicine, Japan.

出版信息

J Comput Assist Tomogr. 1997 Sep-Oct;21(5):713-9. doi: 10.1097/00004728-199709000-00006.

Abstract

PURPOSE

Overestimating the size of hepatic malignancy with helical CT during arterial portography (CTAP) can be a potential pitfall in determining liver resection area. We evaluated the prevalence and extent of overestimation of hepatic malignancy on CTAP in correlation with helical equilibrium phase CT (EPCT) and pathologic findings.

METHOD

CTAP and EPCT in 47 histologically proven malignant hepatic tumors [33 hepatocellular carcinomas (HCCs) and 14 metastases] in 39 patients were retrospectively studied. Nineteen tumors were resected and pathologically evaluated.

RESULTS

The size overestimation ratios (CTAP/EPCT) ranged from 1.02 to 1.56 (mean +/- SD 1.24 +/- 0.16) in HCC and from 1.00 to 2.48 (1.34 +/- 0.42) in metastasis. In 19 surgical specimens, the overestimation ratios (CTAP/specimen) ranged from 1.05 to 1.45 (1.20 +/- 0.13) in HCC and from 1.10 to 1.38 (1.22 +/- 0.10) in metastasis. Histopathologically, flattening of parenchymal structures (100%), atrophy of hepatic cords (95%), sinusoidal congestions (95%), fibrosis and ductular proliferation (58%), and no tumor were seen in peritumoral parenchyma corresponding to perilesional perfusion defects with CTAP.

CONCLUSION

CTAP frequently and significantly overestimates the size of malignant hepatic tumors. This phenomenon is attributable to either benign histopathological changes in the perilesional liver parenchyma caused by parenchymal compression or portal venous obstruction by malignant liver tumors or to a siphoning effect by hypervascular neoplasms.

摘要

目的

在动脉门静脉造影(CTAP)期间,螺旋CT高估肝脏恶性肿瘤的大小可能是确定肝切除范围时的一个潜在陷阱。我们评估了CTAP上肝脏恶性肿瘤高估的发生率和程度,并与螺旋平衡期CT(EPCT)及病理结果进行相关性分析。

方法

回顾性研究了39例患者的47个经组织学证实的肝脏恶性肿瘤[33例肝细胞癌(HCC)和14例转移瘤]的CTAP和EPCT。19个肿瘤被切除并进行了病理评估。

结果

HCC的大小高估率(CTAP/EPCT)范围为1.02至1.56(平均±标准差1.24±0.16),转移瘤的范围为1.00至2.48(1.34±0.42)。在19个手术标本中,HCC的高估率(CTAP/标本)范围为1.05至1.45(1.20±0.13),转移瘤的范围为1.10至1.38(1.22±0.10)。组织病理学上,在与CTAP的病灶周围灌注缺损相对应的肿瘤周围实质中,可见实质结构变平(100%)、肝索萎缩(95%)、窦状充血(95%)、纤维化和小胆管增生(58%),且未见肿瘤。

结论

CTAP经常且显著高估肝脏恶性肿瘤的大小。这种现象可归因于实质压迫或恶性肝肿瘤导致的门静脉阻塞引起的病灶周围肝实质的良性组织病理学改变,或归因于高血供肿瘤的虹吸效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验